MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
- Operating cash flow, 2025
- $56M
- YoY, 2025
- +440.7%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $56M | +440.7% |
| 2024 | $10M | — |
| 2023 | −$71M | — |
| 2022 | −$120M | — |
| 2021 | −$133M | — |
| 2020 | −$89M | — |
| 2019 | −$39M | — |